US has the largest market for dermatology and is also forecast to be the leading market through 2028; GMR Data forecasts $17.3 billion in 2019 growing to $22.8 billion in 2028.The US is a prime target for brand drug manufacturers due to strong patent laws and high per capita health spending. US government data shows that the US has the highest total healthcare spending per capita globally, with $10,403 across 2015. The UK showed per capita spending of $4,935; France had $4,959. According to IMS Health, there are more than 10000 dermatologists and near about 8000 dermatology practices in USA representing a massive 12-billion-dollar market value in this year which will be increased by more 4 billion next year. The increasing demand for the dermatology service is due to various skin disorders, skin cancer and most importantly the cosmetic surgery. The dermatology industry is highly fragmented with consolidation expected due to rising costs and complexity. The dermatology industry is highly fragmented with consolidation expected due to rising costs and complexity. Young dermatologists are increasingly choosing multi-physician settings over solo practices getting financial profile with profit margins averaging 20% in 2012 We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry.